WallStSmart
XFOR

X4 Pharmaceuticals Inc

NASDAQ: XFOR · HEALTHCARE · BIOTECHNOLOGY

$4.10
-0.49% today

Updated 2026-04-29

Market cap
$374.59M
P/E ratio
P/S ratio
10.67x
EPS (TTM)
$-1.87
Dividend yield
52W range
$1 – $5
Volume
0.5M

WallStSmart proprietary scores

33
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$11.67
+184.63%
12-Month target
Intrinsic (DCF)
$30.14
Margin of safety
+88.62%
0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 79.10% QoQ
+ 88.62% below intrinsic value
Risks
- Thin margins at -225.60%
- Negative free cash flow $-18.53M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$2.56M$35.11M$35.11M
Net income$-93.87M$-101.17M$-37.45M$-79.20M$-23.93M
EPS$-1.87
Free cash flow$-77.20M$-96.57M$-138.23M$-88.62M$-18.53M
Profit margin-1,464.61%-225.55%-225.60%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
XFOR$374.59M336.32.06.75.0+88.62%Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

X4 Pharmaceuticals Inc trades at $4.10. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $35.11M. with profit margins at -225.60%. Our DCF model estimates intrinsic value at $30.14.

Frequently asked questions

What is X4 Pharmaceuticals Inc's stock price?
X4 Pharmaceuticals Inc (XFOR) trades at $4.10.
Is X4 Pharmaceuticals Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $30.14.
What is the price target of X4 Pharmaceuticals Inc (XFOR)?
The analyst target price is $11.67, representing +184.6% upside from the current price of $4.10.
What is the intrinsic value of X4 Pharmaceuticals Inc (XFOR)?
Based on our DCF model, intrinsic value is $30.14, a +88.6% margin of safety versus $4.10.
What is X4 Pharmaceuticals Inc's revenue?
TTM revenue is $35.11M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio10.67x
ROE-76.00%
Beta0.33
50D MA$3.91
200D MA$3.46
Shares out0.09B
Float0.06B
Short ratio
Avg volume0.5M

Performance

1 week+4.95%
1 month+12.77%
3 months+9.00%
YTD+6.00%
1 year
3 years
5 years